7,7'-(3,6,9,12-tetraazadispiro[5.2.59.26]hexadecane-6,9-diium-3,12-diyl)bis([1,2,5]oxadiazolo[3,4-d]pyrimidine 1-oxide) Dichloride

ID: ALA5218828

Chembl Id: CHEMBL5218828

PubChem CID: 168297977

Max Phase: Preclinical

Molecular Formula: C20H28Cl2N12O4+2

Molecular Weight: 498.51

Associated Items:

Names and Identifiers

Canonical SMILES:  Cl.Cl.[O-][n+]1onc2ncnc(N3CC[N+]4(CC3)CC[N+]3(CCN(c5ncnc6no[n+]([O-])c56)CC3)CC4)c21

Standard InChI:  InChI=1S/C20H26N12O4.2ClH/c33-29-15-17(25-35-29)21-13-23-19(15)27-1-5-31(6-2-27)9-11-32(12-10-31)7-3-28(4-8-32)20-16-18(22-14-24-20)26-36-30(16)34;;/h13-14H,1-12H2;2*1H/q+2;;

Standard InChI Key:  ZCKQSJGEEBFVIO-UHFFFAOYSA-N

Associated Targets(non-human)

Lyssavirus rabies (44 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Human papillomavirus type 16 (106 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Deltapapillomavirus 4 (1 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Human betaherpesvirus 5 (5122 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Human alphaherpesvirus 1 (11089 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Human alphaherpesvirus 2 (4932 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Human immunodeficiency virus (3636 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Human immunodeficiency virus 1 (70413 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Human alphaherpesvirus 3 (4092 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Human gammaherpesvirus 4 (1538 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Respiratory syncytial virus (3434 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Coxsackievirus B3 (1096 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Influenza A virus (11224 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 498.51Molecular Weight (Monoisotopic): 498.2189AlogP: -2.20#Rotatable Bonds: 2
Polar Surface Area: 163.98Molecular Species: NEUTRALHBA: 12HBD:
#RO5 Violations: 1HBA (Lipinski): 16HBD (Lipinski): #RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: CX LogP: -10.81CX LogD: -10.81
Aromatic Rings: 4Heavy Atoms: 36QED Weighted: 0.22Np Likeness Score: -0.36

References

1. Egorova A, Bogner E, Novoselova E, Zorn KM, Ekins S, Makarov V..  (2021)  Dispirotripiperazine-core compounds, their biological activity with a focus on broad antiviral property, and perspectives in drug design (mini-review).,  211  [PMID:33218683] [10.1016/j.ejmech.2020.113014]

Source